There is an increasing number of reports, however, showing that galectin-7 is overly expressed in cancer cells, most notably in as esophageal, lung and buccal squamous cell carcinomas, thyroid carcinomas, bladder cancer, lymphoma, and breast cancer [7], [20]–[25]. This evidence concerns the gene LGALS7 and cancer.